Planning Commission Calls For Amendment To D&C Act To Monitor Medical
Devices Sector Setter
The Planning Commission has suggested the
amendment of the Drugs and Cosmetics (D&C) Act to include medical
devices incorporating provisions for their risk based classification,
clinical trials, conformity assessments and penalties.
The recommendation has been included in the draft plan document for
the current 12th Five Year Plan, which will be approved shortly. “As
recommended by the Mashelkar Committee, a Central Drug Authority needs
to be set up. This authority would review the issuance of licences for
manufacture and sale of drugs. Once this Authority is in place...
Plastindia To Strengthen Ties With Pharma Sector To Enhance Plastics'
PLASTINDIA Foundation, an apex body of
major associations connected with plastics including government
organisations, expressed interest in exploring better business
opportunities with the pharma industry for the use of plastics in the
packaging of pharma products...
Pharmexcil To Represent India Pavilion At Arab Health 2013 In Dubai
In order to showcase the robust Indian
pharmaceutical industry and also to strengthen relationship with other
countries for export, the Pharmaceuticals Export Promotion Council of
India (Pharmexcil) will participate in the ‘Arab Health 2012’, which
will be held from January 28-31, 2013 at the Dubai International
Convention and Exhibition Centre...
Pharmaceuticals Export Promotion Council Of India
Important Information : Present Status on